The American Society for Microbioogy journal mSphere recently launched a new series of commentaries called “mSphere of Influence.” Young scientists were invited to write about how one or more important papers made a substantial impact on their own work and thinking. The paper “A CRISPR-based approach for proteomic analysis of a single genomic locus” which was a collaborative effort between the labs of Kevin Raney and Alan Tackett was recognized by Lucy Glover in her commentary.
News
Dustyn Barnette Student Highlight
Dustyn is a Ph.D. Student in his 5th year in the Biochemistry and Molecular Biology Department. He joined the laboratory of Dr. Grover P. Miller for his research studies.
He has a B.S. in Biology from Ouachita Baptist University with minors in chemistry and art.
Research Interest Statement
A major obstacle in drug development is the occurrence of drug-induced liver injury (DILI). DILI can cause drugs to be rejected for market approval, or it can be idiosyncratic, meaning that it may not be discovered until after market approval.
The focus of my graduate research is to study metabolic activation of drugs to form toxic metabolites, which is one of the possible causes of idiosyncratic DILI. I am interested in the development and use of in vitro systems and computational models to serve as alternatives to in vivo trials for predicting and investigating mechanisms of drug induced hepatotoxicity. I have conducted thorough analyses of metabolic pathways of three marketed drugs (warfarin, terbinafine, and meloxicam) with special focus on pathways that contribute to bioactivation or detoxification. Through these efforts, I am working to establish the mechanisms that explain the idiosyncratic DILI observed for some drugs. The clinical application of this mechanistic knowledge is to be able to predict which patients will be vulnerable to DILI based on factors that affect metabolism such as genetics, environmental exposures, and drug-drug interactions.
Something Notable about Time as a Graduate Student
Last spring, I got to go to Baltimore to present my research at the annual Society of Toxicology meeting. Of course, the very first thing I did when I got there is take the metro train from the airport to the convention center. When the train got to my final stop, I walked over to the door ready to get off. I had no idea that this station was closed for construction, and the train was only stopping there because it had to wait on a crossing. No worries though, I found this all out very quickly after the train suddenly lurched ahead again, sending my unsuspecting self toppling like a flailing rag doll straight onto the lap of some random guy sitting next to the door. Sometimes, to only way to learn things is the hard way.
Career Goals
Once I get my Ph.D. I want to enroll in a post-doctoral position in a government research lab. Long term, I want my career to facilitate the development, improvement, and use of in vitro systems and computational models as alternatives to in vivo for predicting and investigating mechanisms of drug induced hepatotoxicity.
Experiment or Technique You Would Most Like to Do
I always enjoy when I get to use fluorescent compounds to chemically label the metabolites that I’m studying. There is something very fulfilling about working with brightly colored samples.
Fun fact
I like to hike. One of my favorite trails in Arkansas is the Lost Valley Trail near Ponca. At the hike’s end there’s a big cave with a waterfall in it, but my favorite part is actually around the halfway point. There’s a little cave located a couple hundred feet off the main trail that my cousins and I just stumbled upon by chance one time. You have to crawl to get into it, but once you’re in, you get to see dozens of little aquatic invertebrate fossils all over the walls and ceiling. It looks very cool!
Publications
Comprehensive kinetic and modeling analyses revealed CYP2C9 and 3A4 determine terbinafine metabolic clearance and bioactivation. Dustyn A. Barnette, Mary A. Davis, Noah Flynn, Anirudh S. Pidugu, S. Joshua Swamidass, and Grover P. Miller. Biochemical Pharmacology. October 9, 2019. doi: 10.1016/j.bcp.2019.113661, PMID: 31605674.
CYP2C19 and 3A4 dominate metabolic clearance and bioactivation of terbinafine based on computational and experimental approaches. Mary A. Davis, Dustyn A. Barnette, Noah R. Flynn, Anirudh S. Pidugu, S. Joshua Swamidass, Gunnar Boysen, Grover P. Miller. Chemical Research in Toxicolgoy. 2019 Apr 10. doi: 10.1021/acs.chemrestox.9b00006, PMID: 30925039.
Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approaches. Dustyn A. Barnette, Mary A. Davis, Na L. Dang, Anirudh S. Pidugu, Tyler Hughes, S. Joshua Swamidass, Gunnar Boysen, Grover P. Miller. Biochemical Pharmacology. August 2018, 156, 10-21. doi: https://doi.org/10.1016/j.bcp.2018.07.043, PMID: 30076845.
Stereospecific Metabolism of R- and S-Warfarin by Human Hepatic Cytosolic Reductases. Dustyn A. Barnette, Bryce P. Johnson, Dakota L. Pouncey, Robert Nshimiyimana, Linda Desrochers, Thomas E. Goodwin, Grover P. Miller. Drug Metabolism and Disposition. September 2017, 45 (9) 1000-1007. doi: https://doi.org/10.1124/dmd.117.075929, PMID: 28646078.
Exposure cessation during adulthood did not prevent immunotoxicity caused by developmental exposure to low-level trichloroethylene in drinking water. Kathleen M. Gilbert, Shasha Bai, Dustyn Barnette, and Sarah J. Blossom. Toxicological Sciences. March 2017, 157 (2): 429-437. doi:10.1093/toxsci/kfx061, PMID: 28369519.
Evaluation of virulence and antimicrobial resistance in Salmonella enterica serovar Enteritidis isolates from humans and chicken- and egg-associated sources. Jing Han, Kuppan Gokulan, Dustyn Barnette, Sangeeta Khare, Anthony W. Rooney, Joanna Deck, Rajesh Nayak, Rossina Stefanova, Mark E. Hart, and Steven L. Foley. Foodborne Pathogens and Disease. December 2013, 10 (12): 1008-1015. doi:10.1089/fpd.2013.1518, PMID: 24102082.
Awards
UAMS Graduate Student Association Research Symposium – Third Place for Poster Presentations (Fall 2019)
Arkansas Academy of Sciences Conference – Third Place for Biochemistry/Chemistry Oral Presentation (Spring 2016)
Brian Koss interview about graduate school on KATV
Brian Koss, a graduate student in the Biochemistry and Molecular Biology track, and Bobby McGehee, Dean of the Graduate School, were interviewed on KARK about graduate school at UAMS. Brian is a student in the lab of Alan Tackett.
Congratulations Dr. Nyamugenda
Congratulations to Eugene Nyamugenda, who successfully defended his dissertation entitled “Effect of high-fat diet on the melanocortin-4 receptor (MC4R) neurons in the paraventricular nucleus of the hypothalmus”. Eugene is a student in Giulia Baldini’s laboratory.
Victoria Hwang selected in Regeneron Science Talent Search
Victoria Hwang, a senior at the Arkansas School for Mathematics, Sciences, & the Arts, has been named a top 300 Scholar in the 79th Regeneron Science Talent Search. Victoria was selected for her work entitled “POLKKO GBM-derived Cells Exhibit Increased Replication Catastrophe” in Dr. Robert Eoff’s laboratory. Congratulations Victoria!
December publications
Mechanistic Insights into Chemoresistance Mediated by Oncogenic Viruses in Lymphomas.
Chen J, Kendrick S, Qin Z.
Viruses. 2019
Tresor Mukiza Recognized for Research Publication
Tresor Mukiza, a Ph.D. student at UAMS, received high honors for his first-author publication in the November issue of the journal Genetics. The editors selected the paper to be featured in a Highlight, and cover art for the article was displayed on the journal home page during the month of publication.
“This is a notable accomplishment,” said Wayne Wahls, Ph.D., professor of Biochemistry and Molecular Biology and mentor for Mukiza’s doctoral dissertation research. “It reflects the high quality of Tresor’s research and the importance of his findings to the scientific community.”
In humans, the wrong number of chromosomes (aneuploidy) is the leading cause of spontaneous pregnancy loss, intellectual disability, and congenital birth defects such as Down syndrome. This stems from errors in chromosome segregation during meiosis, which produces the reproductive cells (sperm and eggs) of the parents. Because the fundamental features of meiosis are conserved from fungi to humans, the Wahls’ laboratory uses an exceptionally powerful model organism, the fission yeast S. pombe, to study molecular mechanisms of meiosis.
In their paper, Mukiza and his co-authors Reine Protacio, Ph.D., Mari Davidson, Ph.D., Walter Steiner Ph.D., and Wayne Wahls, Ph.D. report that DNA sequence elements and their binding proteins remodel the structure of chromosomes to regulate the distribution of homologous recombination during meiosis. “This provides important clues about the meiotic origins of aneuploidy,” said Mukiza, “because correctly positioned homologous recombination is essential for the proper segregation of chromosomes in meiosis.”
Mukiza earned a bachelor’s degree in biology with a minor in chemistry, Magna Cum Laude with Distinction in Biology, from Hendrix College. He was just awarded his Ph.D. degree in biochemistry and molecular biology from UAMS. Mukiza’s dissertation research was supported by a $1.2 million grant to Wahls from the National Institute of General Medical Sciences, which is the basic science institute within the National Institutes of Health.
Duah Alkam invited to present at Nanopore Community Meeting
Duah Alkam, a Ph.D. student in Mark Smeltzer‘s and Dave Ussery‘s laboratories was invited to present her work at the Nanopore Community Meeting in New York. A description of her presentation from Oxford Nanopore Technologies is below.
Duah Alkam – PCR-free transposon sequencing (TnSeq): Cas9/dCas9-mediated transposon enrichment
Duah Alkam (University of Arkansas for Medical Sciences) opened the Targeted Sequencing breakout session by introducing the goal of her team: to find therapeutic targets for the prominent bacterial pathogen Staphylococcus aureus. Staphylococcus bacteria are a leading cause of healthcare-associated infections, with Methicillin-resistant S. aureus (MRSA) causing over 80,000 severe infections and over 11,000 deaths per year.
Duah and the team take a whole-genome screening approach to the search for novel therapeutics via transposon sequencing (TnSeq), enabling analysis of the genes that affect the fitness of microorganisms in a particular condition. She described how, in a transposon library, each cell is mutagenized by a transposon – a DNA segment that inserts into a gene, resulting in dysfunction. The transposon library used by Duah and her colleagues is in a background of a clinically-relevant strain of S. aureus; Duah gave an overview of a typical workflow, in which the libraries are grown in different conditions, then enriched for the region of interest. The current protocol for TnSeq requires PCR amplification of the transposon-library junctions prior to sequencing; Duah noted that this method has been used in many papers. However, Duah explained, there’s a problem with this method: inherent bias is introduced through the PCR steps. Looking to overcome this, Duah asked: “can we enrich for the transposon via a PCR-free method?”. Here, Duah explained, the team turned to Oxford Nanopore and decided to explore PCR-free dCas9/Cas9-mediated transposon enrichment.
Duah outlined the four methods tested to investigate Cas9-mediated enrichment and nanopore sequencing of S. aureus TnSeq libraries; in each case, samples were prepared for sequencing without PCR using the Ligation Sequencing Kit and sequenced on the MinION device.
In the first condition, the TnSeq library was sequenced without any enrichment. This no-enrichment condition resulted in just 8,566, or 0.2% of the 5.1m reads representing transposons, as expected – transposons are “pretty rare in the library”. This confirmed the need for enrichment of the transposons.
In the second condition, CRISPR/Cas9 was used to induce a double-stranded cut targeting transposon insertion sites, then the library was sequenced. Duah outlined the CRISPR/Cas9-mediated enrichment method: firstly, the 5′ ends of all strands in the sample are dephosphorylated. Next, the Cas9 enzyme is directed to and cleaves DNA at transposon sites via RNAs including custom transposon-specific probes. This reveals phosphorylated ends, to which sequencing adapters can be ligated so that the enriched DNA can be sequenced. In this dataset, transposons were successfully enriched, representing 45% of reads in sequencing – “we were very excited when we saw this” – but sequencing yield was depleted, so that this was comprised of 3.7k reads.
To investigate whether yield could be improved, in the third condition, dCas9 – “dead” Cas9, an inactive form of the enzyme which does not cut the DNA – and biotinylated RNA probes were used, so that the biotinylated targets could be captured using Streptavidin beads then prepared for sequencing. Whilst this protocol resulted in only 0.8% transposon reads, sequencing output was higher, resulting in 94.6k reads.
Aiming to make the most of the enrichment from Cas9 and yield from dCas9, in the last condition, a combination of these methods were used. dCas9 and biotinylated probes were first used to capture the DNA, then active Cas9 was used to cleave the transposons at a single site prior to sequencing. Here, enrichment was lower than when using Cas9 alone, with 31% of reads representing transposons, but as sequencing output was higher, 19.4k reads were on-target.
Summarising, Duah concluded that she and her team had successfully devised and utilized a PCR-free method of transposon enrichment from a TnSeq S. aureus library, representing the first time this has been achieved without PCR. Furthermore, the use of dCas9 in pulldown prior to cleavage by Cas9 improved sequencing yield, enabling a greater number of transposon reads. They are now optimizing their protocol to further improve sequencing yield and recover greater numbers of insertions.
Congratulations Dr. Mukiza!
Congratulations to Tresor O. Mukiza, who successfully defended his dissertation entitled “Multiple DNA Sequence-Specific Protein-DNA Complexes Activate Meiotic Recombination Hotspots Via Chromatin Remodeling”. Tresor is a student in Wayne Wahls‘ laboratory.
New position for Jacy Wagnon
Jacy Wagnon, who earned her Ph.D. in Dr. Wayne Wahls’ laboratory, has now obtained a tenure-track faculty position at The Ohio State University. Doctor Wagnon is an Assistant Professor in the Department of Neuroscience, with research interests in epilepsy, neurodegenerative disorders, and genetics of neurological diseases.